Novavax Inc. delivered just a small fraction of the 2 billion COVID-19 shots the company plans to send around the world in 2022 and has delayed first-quarter shipments in Europe and lower income countries such as the Philippines, public officials involved in their government’s vaccine rollouts told Reuters.
Medable Launches Partner Network to Accelerate Innovation and Simplify Deployment of Decentralized Clinical Trials
Business, CVS Health, Data, Decentralized Clinical Trials, Direct-to-patient engagement, Health Technology, Innovation, Partnerships, R&D, Remote Site Access Technology, Software, TelemedicineMedable Inc., the leading software provider for patient-centered clinical trials, launched the Medable Partner Network – uniting a diverse ecosystem of technology, service, data, site, and direct-to-patient partners that work together to accelerate deployment of decentralized clinical trials.
The U.S. Food and Drug Administration is investigating a possible death risk for TG Therapeutics’ Ukoniq (umbralisib), which is indicated for two types of lymphoma.
Many babies of mRNA-vaccinated moms have antibodies at 6 months; Moderate COVID tied to higher childbirth risks
Birth, Covid-19 Data, COVID-19 Infections, COVID-19 Studies, Eli Lilly, Infants, JAMA, Monoclonal Antibodies, Mothers, Pregnancies, R&D, Regeneron Pharmaceuticals, Severe Covid-19, United StatesAt 6 months of age, babies born to mothers vaccinated against COVID-19 during pregnancy are more likely to have antibodies against the virus in their blood than babies born to unvaccinated mothers who were infected while pregnant, a small study suggests. Additionally, contracting COVID-19 late in pregnancy is linked with a higher risk for obstetric complications, new data suggest.
A new variant of HIV was recently discovered in Europe that is more contagious and more deadly – the virus degrades the immune system into AIDS twice as fast as previous strains.
U.S. coronavirus deaths surpass 900,000, driven in part by Omicron surge
Africa, Brazil, Coronavirus Disease (COVID-19) Pandemic, COVID-19 Deaths, COVID-19 Vaccinations, Delta Variant (B.1.617.2; India), Health Officials, India, Iowa, Joe Biden, Omicron (B.1.1.529) (South Africa), Peru, Reuters Data, Russia, United StatesThe coronavirus pandemic reached a grim new milestone in the United States on Feb. 4 with the nation’s cumulative death toll from COVID-19 surpassing 900,000, even as the daily number of lives lost began to level off, according to data collected by Reuters.
U.S. health officials on Feb. 4 said they are considering lengthening the recommended interval between the first two doses of the most widely used COVID-19 vaccines to eight weeks to lower the risk of heart inflammation and improve their effectiveness.
Specialty vaccine company Valneva, along with Pfizer, reported positive Phase II data from their clinical trial evaluating a Lyme disease vaccine candidate.
Belgium-based UCB hit the mark in the company’s Phase III clinical trial assessing zilucoplan as a potential treatment for adults with generalized myasthenia gravis, a rare autoimmune disease. Vanda Pharmaceuticals’ late-stage study of tradipitant as a treatment for the symptoms of gastroparesis, a digestive disorder, failed to meet the trial’s primary endpoint.
A record number of people – totaling more than 3.6 million – were unable to work due to illness during the week in January that officials gathered data for the benchmark U.S. monthly employment report, which coincided with the peak in infections from COVID-19.